BioXcel Therapeutics Inc (FRA:BX2)
€ 1.892 0.006 (0.32%) Market Cap: 72.49 Mil Enterprise Value: 98.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

BioXcel Therapeutics Inc Annual Shareholders Meeting Transcript

May 20, 2020 / 01:00PM GMT
Release Date Price: €43.4 (-3.56%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the BioXcel Therapeutics Annual Meeting of Stockholders. (Operator Instructions)

I would now like to hand the conference over to your speaker, Peter Mueller. Please go ahead, sir.

Peter R. Mueller
BioXcel Therapeutics, Inc. - Independent Chairman

Good morning, everybody. I am Dr. Peter Mueller, the Chairman of the Board of Directors of BioXcel Therapeutics and the Chairperson of today's meeting. I'm very happy to welcome you to our 2020 Annual Meeting of Stockholders. I first want to take a moment to address these unprecedented times. The COVID-19 pandemic has truly affected each and every one of us. I personally want to thank all of the health care and essential workers who are tirelessly fighting on the front lines.

Before I call the meeting to order, I'd like to introduce you to other members of the Board of Directors who are with us today. The other members of the Board joining us today are Dr. Vimal Mehta, our President and Chief Executive Officer; Dr. Krishnan Nandabalan

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot